Navigation Links
Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
Date:2/1/2013

PARSIPPANY, N.J., Feb. 1, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), announced today that it intends to release fourth quarter 2012 financial results on Tuesday, February 19, 2013, prior to the open of the U.S. financial markets.  The Company will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, February 19, 2013 to discuss its financial results.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573, and the Conference ID is 94810189.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

About Actavis, Inc.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

Actavis is the world's third-largest generics prescription drug manufacturer.  Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 coun
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
2. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
3. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
4. Zimmer Reports Fourth Quarter and 2012 Financial Results
5. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
6. Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after Market Close on Thursday, February 14
7. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
8. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
9. Danaher Reports Record Fourth Quarter 2012 Results
10. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
11. Thoratec Schedules Fourth Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 /PRNewswire/ - Medicure Inc. (the ... Directors has approved the grant of an aggregate of ... employees and consultants of the Company pursuant to the ... set to expire on the tenth anniversary of the ... the third anniversary of the date of grant and ...
(Date:3/27/2015)... Telbec/ - Russell Williams , President of ... the 2015-2016 Quebec Budget, noting the fiscal discipline and ... industry. However, the association is concerned about the decline ... government,s intent to strive for a balanced budget this ... Quebec,s economic development is encouraging," said ...
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending ... as the country,s manufacturing leader in innovation and economic ... to the  analysis , the industry had the highest ... accounting for 27 percent of average annual R&D spending ... on Medicare Part D - Medicare Part D ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Week in Review: The Latest from PhRMA 2
... SPEX ) reported that patient recruitment for its Phase ... Naturlose(R), has begun in,India. Expectations for India are to ... the pivotal Phase 3 trial. "Now that enrollment efforts,are ... trial will be completed,on schedule as reported during the ...
... only participant in Texas for TFAS spinal implant, PLANO, ... again in motion preserving technology by continuing to advance,spinal device ... (TFAS)(R)., Dr. Barton Sachs of Texas Back Institute performed ... Texas resident was one of,the first 40 people worldwide to ...
Cached Medicine Technology:Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2Texas Back Institute Leads Way in New Facet Joint Clinical Trial 2
(Date:3/30/2015)... 2015 Bunion Bootie is a ... for family members, friends...and yourself and save. For a limited ... an additional 10%, on top of discounts already offered when ... at checkout. The more Bunion Booties purchased, the more money ... bunion pads, Bunion Bootie can be worn comfortably and easily ...
(Date:3/29/2015)... March 29, 2015 Women’s Excellence ... treatment. Secondary to their location in Birmingham, they ... option. They continue to be affiliated with Crittenton, ... , Menopause is a normal condition that all women ... any of the changes a woman goes through either ...
(Date:3/29/2015)... The Claudia Cohen Research Foundation ... announce today that Dr. Beth Y. Karlan has been ... Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 ... Oncology 46th Annual Meeting on Women's Cancer in Chicago. ... Cancer Program at the Samuel Oschin Comprehensive Cancer Institute ...
(Date:3/29/2015)... 2015 Final Cut Pro X ... Pixel Film Studios, entitled TranSports. , “TranSports is ... Final Cut Pro X,” said Christiana Austin, CEO of ... needed to effortlessly transition using this cool sports transition ... and uniquely styled transition pack for Final Cut Pro ...
(Date:3/28/2015)... Tucson, AZ. (PRWEB) March 28, 2015 ... according to a new study by researchers ... (HSPH). , Produced with the support of the Coffee ... the journal Molecular Psychiatry this past fall, the study—one ... a meta-analysis of genomic data from more than 120,000 ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie, the Ultimate Solution for Bunion Relief, Offers Special Savings This Easter 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3
... hay fever symptoms could be reduced by 60% with the ... in Baltimore. ,Dr. Peter Socrates Creticos, medical director ... Johns Hopkins University School of Medicine and his team tested ... ,The study was conducted on 25 volunteers with ...
... health shops to overcome depression only one actually has any ... have said that St John's Wort is the only alternative ... others including gingko biloba, ginseng, cat's claw, royal jelly and ... serious drug interactions". ,The experts, Joyce Reed, a ...
... a dozen top universities on Tuesday by the government ... hasten scientific discoveries towards better health care thereby trying ... ,This idea came about because of the increased specialization ... ever for scientists from different fields to share the ...
... the All India Institute of Medical Sciences (AIIMS), including ... postponed its medical students' semester examination scheduled for later ... their hostel rooms after a seventh semester student died ... virus include medical students, resident doctors and other hospital ...
... and biotech major Wockhardt Limited announced on Tuesday ... $150 million that will help it broaden its presence ... a larger footprint in Europe spread over Britain, Ireland ... ,'European business will now exceed $200 million, accounting for ...
... tuberculosis that caused a major outbreak in a British school ... has surfaced again, directing its destruction on a specific ethnic ... a study to examine the potency of the 2001 outbreak. ... disease with the BCG vaccine. ,The severe strain, ...
Cached Medicine News:Health News:DNA vaccine for ragweed allergies 2Health News:Unscientific Depression Drugs aplenty in Health Stores 2Health News:NIH Funds the Development of National Consortium of Universities 2
... Used for temporary ... ureteropelvic junction to the ... peel-open packages. Intended for ... evaluation is advised; C-Flex® ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: